Does DINOPROSTONE Cause Uterine hyperstimulation? 65 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 65 reports of Uterine hyperstimulation have been filed in association with DINOPROSTONE (CERVIDIL). This represents 9.0% of all adverse event reports for DINOPROSTONE.
65
Reports of Uterine hyperstimulation with DINOPROSTONE
9.0%
of all DINOPROSTONE reports
1
Deaths
13
Hospitalizations
How Dangerous Is Uterine hyperstimulation From DINOPROSTONE?
Of the 65 reports, 1 (1.5%) resulted in death, 13 (20.0%) required hospitalization, and 9 (13.8%) were considered life-threatening.
Is Uterine hyperstimulation Listed in the Official Label?
Yes, Uterine hyperstimulation is listed as a known adverse reaction in the official FDA drug label for DINOPROSTONE.
What Other Side Effects Does DINOPROSTONE Cause?
Foetal exposure during pregnancy (67)
Off label use (52)
Premature separation of placenta (48)
Maternal exposure during pregnancy (46)
Postpartum haemorrhage (40)
Premature baby (40)
Drug ineffective (36)
Foetal heart rate deceleration abnormality (36)
Premature delivery (33)
Exposure during pregnancy (32)
What Other Drugs Cause Uterine hyperstimulation?
Which DINOPROSTONE Alternatives Have Lower Uterine hyperstimulation Risk?
DINOPROSTONE vs DINUTUXIMAB
DINOPROSTONE vs DINUTUXIMAB BETA
DINOPROSTONE vs DIOSMIN
DINOPROSTONE vs DIOSMIN\HESPERIDIN
DINOPROSTONE vs DIOVAN